Reference : Management of high blood pressure in peripheral arterial disease
Scientific journals : Article
Human health sciences : Multidisciplinary, general & others
Human health sciences : Urology & nephrology
Management of high blood pressure in peripheral arterial disease
Krzesinski, Jean-Marie mailto [Université de Liège - ULiège > Département des sciences cliniques > Néphrologie >]
Acta Chirurgica Belgica
Acta Medica Belgica
Yes (verified by ORBi)
[en] Peripheral arterial disease ; Hypertension ; Blood pressure ; Coronary arterial disease
[en] Arterial hypertension (HTA) is a promoter of peripheral arterial disease (PAD) in association with other atherosclerotic risk factors factors. Systolic HTA is the most frequently noted form in such disease, secondary to marked increase in large artery siffness. The existence of PAD confers on the hypertensive patient a very high cardiovascular (CV) risk, requiring an intensive global therapeutical approach. Treating HTA is one of such beneficial actions. The optimal blood pressure (BP) to be reached is at least < 140/90 mmHg but lower BP should be targeted if possible (< or = 130/80 mmHg). First of all, a modification of the lifestyle and diet should be proposed. But to reach such a low target, different antihypertensive agents must be very often used in association. The inhibitors of the renin-angiotensin system constitute one of the main axis of such drug treatment, after having avoided the pitfall of renal artery stenosis.

File(s) associated to this reference

Fulltext file(s):

Open access
Management.pdfPublisher postprint81.52 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.